Wegovy Pill dosing chart: Complete titration schedule (2026)
The Wegovy pill follows a four-phase titration schedule, starting at 1.5 mg and reaching 25 mg over approximately 3 months.
Key highlights
- The Wegovy pill is the first FDA-approved oral GLP-1 for chronic weight management. It contains semaglutide as its active ingredient and is taken orally once daily.
- The Wegovy pill is started at the lowest therapeutic dose (1.5 mg), and its dosage is increased gradually until the 25 mg maximum dose is reached. This helps reduce side effects like nausea, vomiting, and stomach discomfort.
- The pill must be taken first thing in the morning with no more than 4 ounces of plain water. Patients must wait 30 minutes before eating, drinking, or taking other medications.
- The Wegovy pill is suitable for patients who prefer needle-free treatment and room-temperature storage. The injection may be better for those who prefer once-weekly dosing.
- Eligible and commercially insured patients may pay as little as $25 per month with the Novo Nordisk Savings Offer. Self-pay prices generally range between $149 and $299 per month, depending on dose.
The Wegovy pill is the first and only oral GLP-1 (glucagon-like peptide-1) medication. It was approved by the U.S Food and Drug Administration (FDA) on December 22, 2025, for chronic weight management. Unlike Wegovy injections, which are administered once weekly, the Wegovy pill is taken daily with plain water 30 minutes before eating, drinking, or taking other medications to ensure proper absorption and efficacy.
The Wegovy tablet follows a four-phase dose escalation schedule. The medication is available in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths. Your healthcare provider will typically start your treatment with the lowest therapeutic dose, 1.5 mg (starting dose of Wegovy pill), and increase it gradually after 30 days according to your body’s tolerance. This gradual dose escalation helps your body adjust and reduce the risk of common gastrointestinal side effects.
In this article, we will discuss the complete dosing schedule, administration rules, and a comparison with the Wegovy injection, so you can understand how it works, what to expect, and how to use it correctly for the best results.
What is the Wegovy Pill?
The Wegovy pill is a once-daily oral GLP-1 weight loss medication that was approved by the FDA on December 22, 2025, for chronic weight management and reducing the risk of cardiovascular events when used along with a reduced-calorie diet and increased physical activity.
The medication contains the same active ingredient, semaglutide, as Wegovy injections, Ozempic, and Rybelsus. It works by mimicking the GLP-1 hormone to help regulate appetite, reduce food intake, and support weight reduction.
Wegovy is approved for adults with obesity (BMI ≥30) or those who are overweight (BMI ≥27) with at least one weight-related condition, such as hypertension or type 2 diabetes.
Wegovy Pill dosing chart (titration schedule)
Wegovy Pill is available in 1.5 mg, 4 mg, 9 mg, and 25 mg dosage strengths. Your healthcare professional will typically start the medication with the lowest therapeutic dose (1.5 mg) and increase the dose gradually every 30 days until you reach the 25 mg dose, which is the maximum maintenance dosage. This gradual escalation helps your body adjust and reduce the risk of gastrointestinal side effects such as nausea, vomiting, diarrhea, and stomach pain.
These side effects are temporary and usually fade on their own. However, your healthcare provider may delay a dose increase or decrease the dose if you are experiencing persistent side effects. Never adjust your dose without consulting your prescriber.
| Phase | Month | Daily dose | Duration | Purpose |
|---|---|---|---|---|
| Initiation | Month 1 (Days 1–30) | 1.5 mg | 30 days | Tolerability and acclimation |
| Step-Up 1 | Month 2 (Days 31–60) | 4 mg | 30 days | Begin increasing GLP-1 activity |
| Step-Up 2 | Month 3 (Days 61–90) | 25 mg | 30 days | Appetite suppression increases |
| Maintenance | Month 4+ (Day 91 onward) | 25 mg | Ongoing | Full therapeutic weight loss dose |
Managing side effects during dose increases
Gastrointestinal side effects such as nausea, vomiting, and diarrhea are common while taking GLP-1 medication and usually appear during the start of the medication or when the dose is increased. If the side effects are persistent and severe at the 9 mg or 25 mg dose, consult with your healthcare provider for medical guidance. They may prescribe you a lower dose (1.5 mg or 4 mg) for the next 30 days while your body gets used to the medication.
Why does the dose start so low?
Your healthcare provider will typically start the Wegovy pill at a low dose to reduce the risk of side effects and improve tolerability. GLP-1 medications can cause nausea, vomiting, and diarrhea if started at a high dose too quickly. Therefore, increasing the dose gradually allows your body to adapt over time.
According to the OASIS 4 trial, about 46.6% of patients taking the pill experienced nausea, compared to 18.6% with the placebo. The incidence of side effects was greater at higher therapeutic doses.
What happens if I need more time at a dose?
The 30-day escalation period is a minimum guideline, not a fixed rule. The official approach is to increase the dose after 30 days according to your body’s tolerance, which means your healthcare provider can keep you at the same dose longer if you’re still experiencing side effects.
If nausea or other symptoms are persistent and do not settle over time, your healthcare provider may recommend that you stay on your current dose for an extra few weeks before moving up. This is common practice to improve tolerability. Don’t adjust the dose on your own. Always consult with your healthcare provider for medical advice to avoid unintended side effects.
How to take the Wegovy Pill: Administration rules
You must follow the administration rules correctly to ensure the proper absorption and effectiveness of the medication. Oral semaglutide uses a special absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl)amino]caprylate), which helps the medication pass through the stomach lining. Food, coffee, and other liquids interfere with this process and can significantly reduce absorption of the medication into your bloodstream. Follow these steps to maximize the absorption and effectiveness of the medications.
- Take the pill in the morning on an empty stomach at the same time of day, before eating or drinking anything other than water.
- Swallow the tablet with no more than 4 ounces (½ cup or 120 ml) of plain water only. Do not use coffee, tea, juice, milk, soda, or other liquids. Less water is actually better for absorption.
- Wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medications. Avoid coffee and medications like thyroid pills during this window, as they can interfere with absorption and reduce the effectiveness of the medication.
- Swallow the whole pill. Do not crush, split, or chew the tablet.
- Store the medication in the original child-resistant bottle at room temperature (68°F–77°F / 20°C–25°C) in a dry place.
- Do not store the pills in the bathroom because heat and humidity can damage the medication and reduce stability.
If you eat or drink anything other than water before taking the pill, SNAC cannot work properly, and significantly less medication will reach your bloodstream, which can reduce the efficacy.
In addition, Wegovy slows stomach emptying, which can affect how other oral medications are absorbed. This is especially important for patients taking thyroid medications, oral contraceptives, or other time-sensitive drugs. Discuss with your healthcare provider about how to time your medications safely. Clinical studies show that patients who don’t follow the empty-stomach protocol consistently experience less weight loss.
What if I miss a dose?
If you miss a dose of the Wegovy pill, skip it completely and take your next dose the next morning at your regular time. Do not take two doses in one day or take the missed dose later in the day, since the medication must be taken on an empty stomach in the morning for proper absorption. You can use the Following tools to stay consistent:
- Phone alarms or calendar reminders
- Medication tracking apps
- WeGoTogether® reminder support program
Taking the pill consistently and correctly helps maximize its effectiveness.
Wegovy Pill clinical results: How much weight can you lose?
Clinical trial results show that the Wegovy pill can lead to significant weight loss when taken consistently. In the OASIS 4 clinical trial, 307 adults with obesity or overweight and at least one weight-related condition, such as hypertension or hyperlipidemia, participated in the study. After 64 weeks, participants taking oral semaglutide 25 mg achieved an average weight loss of 16.6% with full treatment adherence, compared to 2.7% with placebo. In the more conservative real-world analysis, which included missed doses and treatment interruptions, the average weight loss was still around 13.6%. Furthermore, participants who remained consistent on the treatment lost 20% or more of their body weight.
These weight loss results of the Wegovy pill were comparable to the Wegovy once-weekly injection. According to the STEP 1 clinical trial, participants taking injectable semaglutide 2.4 mg lost 14.9% of their body weight as compared to placebo. However, individual results vary depending on medication adherence, diet, physical activity, and individual metabolism.
The FDA approved the Wegovy pill based on the OASIS clinical trials and SELECT cardiovascular outcomes.
Wegovy Pill vs. Wegovy Injection: Full comparison
The Wegovy pill and Wegovy injection contain the same active ingredient, semaglutide, and both are FDA-approved for chronic weight management. However, they differ in how they are taken, stored, priced, and incorporated into daily life. The Wegovy pill is taken once daily on an empty stomach, while the injection is administered once weekly (on the same day of the week) subcutaneously in the thigh, abdomen, or upper arm, using a prefilled pen. The pill is suitable for patients who prefer to avoid injections or need a treatment option that does not require refrigeration. In comparison, the injection may be more convenient for people who do not want to follow strict morning dosing instructions every day.
Clinical trial data suggest both forms produce comparable weight loss results. In the OASIS 4 trial, the oral pill produced about 13.6–16.6% average weight loss, while the STEP 1 trial showed around 14.9% average weight loss with the injection. Self-pay pricing also differs. The pill starts at a lower monthly cost ($149–$299, depending on dose), while injectable maintenance doses can cost up to $349 per month.
The right choice depends on several factors, such as medication adherence, comfort with injections, insurance coverage, lifestyle, storage preferences, side effects, and long-term treatment goals. Patients should discuss these factors with their healthcare provider before deciding which form of Wegovy best fits their needs.
| Factor | Wegovy Pill (Oral) | Wegovy Injection (Pen) |
|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide |
| Frequency | Once daily | Once weekly |
| Starting Dose | 1.5 mg/day | 0.25 mg/week |
| Maintenance Dose | 25 mg/day | 2.4 mg/week |
| Max Approved Dose | 25 mg/day | 7.2 mg/week (Wegovy HD) |
| Avg. Weight Loss (trials) | ~13.6–16.6% | ~14.9% |
| Timing Restrictions | Strict (empty stomach, 30-min wait) | Flexible (any time, with or without food) |
| Administration | Swallow with ≤4 oz water | Subcutaneous injection (abdomen, thigh, upper arm) |
| Needle Required | No | Yes |
| Storage | Room temp (68–77°F) | Refrigerate; room temp up to 56 days |
| Approved Age | Adults only (18+) | Adults + adolescents 12+ |
| Self-Pay Cost (approx.) | ~$149–$299/month | ~$199–$349/month |
| Absorption Variability | Higher (food/timing sensitive) | Lower (direct bloodstream entry) |
Who should consider the pill?
Wegovy pills are not suitable for everyone. You may be a good candidate for the Wegovy pill if:
- You have a fear of needles or feel anxious about injections.
- You travel frequently and want a treatment that does not require refrigeration. Unlike the injectable pen, the pill can be stored at room temperature and does not require refrigeration, making it easier to carry during flights or work trips.
- You want a lower out-of-pocket starting cost compared to injectable GLP-1 options.
- You are comfortable following a strict daily morning routine for dosing.
- Your insurance covers the pill but not the injection.
Who should consider the injection?
You may be a good candidate for the Wegovy injection if:
- You prefer once-weekly dosing instead of taking a pill every morning.
- You take other morning medications (such as thyroid medication) that cannot be delayed for 30 minutes.
- You are an adolescent (ages 12+), since the injection is approved for this age group.
- Your healthcare provider recommends the injection as part of management for MASH (metabolic dysfunction-associated steatohepatitis).
- You are already using the injection and want to stay consistent with your current routine
Wegovy Pill 25 mg vs Wegovy Injection 7.2 mg
The Wegovy pill and Wegovy injection both contain semaglutide, but they differ significantly in dosing, administration, and clinical use. The comparison of the Wegovy 25 mg pill and the Wegovy 7.2 mg injection is summarized below:
| Feature | Wegovy Pill 25 mg | Wegovy Injection 7.2 mg |
|---|---|---|
| Form | Oral tablet | Weekly injection pen |
| Active ingredient | Semaglutide | Semaglutide |
| FDA status | FDA-approved oral GLP-1 for chronic weight management, and lowering the risk of cardiovascular events in patients with stablished heart diseases. | Higher-dose injectable Wegovy option for an extra weight loss |
| Dose frequency | Once daily | Once weekly |
| Administration | Taken first thing in the morning on an empty stomach | Injected under the skin once weekly |
| Food restrictions | Must wait 30 minutes before eating, drinking, or taking medications | No fasting requirements |
| Water requirement | No more than 4 oz plain water | Not applicable |
| Storage | Room temperature | Refrigeration required before use |
| Convenience | Needle-free, travel-friendly | Less frequent dosing |
| Why is the dose higher | Stomach breaks down part of the medication before absorption | Injected directly into the body |
| Clinical weight loss results | 13.6–16.6% average weight loss | Weight loss approaching 20% in some higher-dose studies |
| Best suited for | Patients who prefer pills and no refrigeration | Patients who prefer weekly dosing |
| Main challenge | Strict timing and fasting instructions | Requires injections |
| Insurance/coupon eligibility | Eligible for Wegovy Savings Offer | Eligible for Wegovy Savings Offer |
Wegovy Pill side effects by dose phase
Most Wegovy pill side effects are GI-related, such as nausea, stomach discomfort, constipation, vomiting, or diarrhea. These side effects usually become more noticeable at the start of the treatment or when the dose increases, and often improve as your body adjusts to the medication over time.
The gradual 30-day dose escalation schedule is specifically designed to make these side effects easier to tolerate. The side effects of the Wegovy pill, according to the dose, are summarized below.
| Side Effect | Estimated Frequency (OASIS 4) | When Most Likely | Management Tips |
|---|---|---|---|
| Nausea | ~46.6% | Dose escalation phases | Eat bland, low-fat foods; avoid lying down after eating |
| Vomiting | ~30.9% | Dose escalation phases | Small, frequent meals; stay hydrated |
| Diarrhea | Common | Throughout treatment | Hydration; avoid high-fat or spicy foods |
| Constipation | Common | Throughout treatment | Increase fiber and water intake |
| Abdominal Pain | Common | Especially early | Smaller meal portions |
| Headache | Common | Early phases | Hydration; rest |
| Fatigue | Common | Early phases | Usually resolves; maintain nutrition |
| Hair Loss | Less common | Later in treatment | Temporary; prioritize dietary protein |
GLP-1 receptor agonists are not suitable for everyone. Some rare but serious risks with Wegovy include pancreatitis, gallbladder problems, and increased risk of diabetic retinopathy. GLP-1 receptor agonist drugs can cause low blood sugar (hypoglycemia) in patients with type 2 diabetes; therefore, it is not recommended to take these medications with other glucose-lowering medications such as metformin or sulfonylurea.
GLP-1 medications are contraindicated in individuals with a history of thyroid tumors or multiple endocrine neoplasia type 2 (MEN2). Consult with your healthcare provider immediately if you experience severe abdominal pain, vision changes, neck swelling, trouble swallowing, or difficulty breathing. Do not use Wegovy if you are trying to conceive, pregnant, or breastfeeding.
Switching between Wegovy Pill and Injection
Patients can switch between the Wegovy pill and injection, but the transition should always be coordinated carefully with your healthcare provider. The timing and dose depend on which form you are currently using and how well you tolerate semaglutide.
Switching from Wegovy Injection (2.4 mg) to the Pill
If you want to switch from the Wegovy injection to the pill, you should wait one week after your last 2.4 mg injection dose before starting the oral medication. Patients who are already on the maintenance dose of Wegovy injection can usually begin the Wegovy pill at 25 mg once daily without restarting the full titration schedule. However, your healthcare provider will determine the exact timing and starting dose based on your treatment history and tolerability.
If you have experienced significant nausea or other gastrointestinal side effects while using the 2.4 mg injection, your healthcare provider may start you on the 9 mg pill dose first before increasing to 25 mg to help improve tolerability and reduce side effects.
Switching from Wegovy Pill to the Injection
If you are switching from the Wegovy pill to the injection, you can usually start the injection the day after taking your last pill dose. Patients who are already tolerating the oral medication may begin at the 1.7 mg or 2.4 mg injection maintenance dose by consulting with their healthcare provider without restarting the injection titration schedule from 0.25 mg.
Do not use the Wegovy pill and injection at the same time, as it can increase the risk of side effects. Wegovy contains semaglutide as its active ingredient and should not be combined with other semaglutide-containing medications such as Ozempic or Rybelsus, or with other GLP-1 receptor agonists.
Wegovy Pill vs. Rybelsus: What’s the difference?
Rybelsus and Wegovy pills both contain semaglutide as their active ingredient, but they are not used for the same purpose. Rybelsus is FDA-approved to improve blood sugar control in adults with type 2 diabetes, while the Wegovy pill is FDA-approved for chronic weight management and cardiovascular risk reduction in adults.
The dosage strength of both medications is also different. Rybelsus is available in 1.5 mg, 4 mg, and 9 mg strengths, while the Wegovy pill is available in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths.
Your stomach contains acid that can destroy the pill or affect the absorption of oral semaglutide. These medications contain a special absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl)amino]caprylate). SNAC temporarily protects semaglutide from being broken down by stomach acid and helps the medication pass through the stomach lining into the bloodstream. The 25 mg Wegovy is not twice as strong as 14 mg because only a small amount of oral semaglutide is absorbed through the stomach. The higher Wegovy dose is designed to deliver enough medication for weight loss, while Rybelsus is formulated for blood sugar control in type 2 diabetes.
Switching from Rybelsus to Wegovy Pill
Wegovy and Rybelsus are not considered interchangeable, and there is currently no Rybelsus dose equivalent to the typical Wegovy maintenance dose. However, patients may switch from Wegovy injections to the Wegovy pill by consulting with their healthcare provider.
Your doctor may switch you from Rybelsus to Wegovy Pill if Rybelsus was being used off-label for weight loss. Wegovy uses higher doses for chronic weight management. Your provider may start with a lower Wegovy dose and gradually increase the dose to improve tolerability.
If Rybelsus was prescribed for type 2 diabetes management and you want to move to an injectable option, your healthcare provider may consider Ozempic instead, as it is also approved for type 2 diabetes.
Wegovy Pill: Eligibility, cost, and access
Wegovy pill is less expensive than the injection. Let’s review the eligibility criteria and the cost of the Wegovy pill:
Who is eligible for the Wegovy Pill?
The Wegovy pill FDA-approved eligibility criteria are for:
- Adults aged 18 and older with a BMI of 30 kg/m² or higher (obesity)
- Adults with a BMI of 27 kg/m² or higher (overweight) who also have at least one weight-related condition, such as high blood pressure (hypertension), type 2 diabetes, high cholesterol level (hypercholesterolemia), or cardiovascular disease
The medication should be used alongside a reduced-calorie diet and increased physical activity for the best results. The oral Wegovy pill is not approved for adolescents under 18 years old. However, the injectable Wegovy pen is approved for adolescents aged 12-17.
How much does the Wegovy Pill cost?
The cost of the Wegovy pill depends on insurance coverage, dose, and location of the pharmacy. Eligible patients with commercial insurance may pay as little as $25 per month using the Novo Nordisk Savings Offer.
For those without insurance, the manufacturer offers discounted pricing to self-pay patients through NovoCare Pharmacy. The starter dose is $149 per month, while maintenance doses such as 25 mg cost $299 per month. The oral pill is often $50–$100 less expensive at similar treatment phases compared to the Wegovy injection.
Patients can also access the Wegovy pill through major pharmacies and telehealth platforms, including CVS, Costco, NovoCare Pharmacy, Ro, LifeMD, WeightWatchers telehealth, and GoodRx.
Frequently asked questions (FAQs)
What is the starting dose of the Wegovy pill?
The starting dose of the Wegovy pill is 1.5 mg once daily for the first 30 days. This low starting dose helps your body adjust to the medication and reduces the risk of gastrointestinal side effects such as nausea, vomiting, diarrhea, and stomach pain. Your healthcare provider will typically increase the dose every 30 days, according to your body tolerance, until you reach the 25 mg maintenance dose.
How long does it take to reach the full Wegovy pill dose?
It usually takes about 3 months (90 days) or more (if you experience side effects) to reach the full therapeutic maintenance dose (25 mg). Your healthcare provider increases the dose gradually after 30 days to reach the maximum dose according to your body’s tolerance.
Can I take the Wegovy pill with coffee or other drinks?
No. You should take the Wegovy pill with plain water only, using no more than 4 ounces. Coffee, tea, juice, soda, or other drinks can interfere with how your body absorbs semaglutide and may reduce the medication’s effectiveness. You must wait for at least 30 minutes before drinking anything else or eating after taking the medication.
What happens if I miss a Wegovy pill dose?
If you miss a Wegovy pill dose, skip it completely and take your next scheduled dose the following morning. Do not take an extra dose later in the day or double up to make up for the missed dose. Missing an occasional dose usually does not require dose adjustment, but missing doses regularly can reduce the medication’s effectiveness over time.
Is the Wegovy pill as effective as the injection?
Yes, the Wegovy pill is as effective as an injection. Clinical trial data suggest the Wegovy pill and injection produce similar weight loss results. In the OASIS 4 clinical trial, patients taking the oral pill lost about 13.6-16.6% of body weight over 64 weeks, while the STEP 1 trial showed around 14.9% weight loss with the weekly injection.
However, researchers have not directly compared the pill and injection in the same head-to-head clinical trials. Therefore, it is not possible to say one is definitively more effective than the other based on current evidence.
What is the maximum dose of the Wegovy pill?
The maximum FDA-approved dose of the Wegovy pill is 25 mg once daily. This is the maximum maintenance dose, which is used for long-term weight management. Currently, there is no FDA-approved oral dose higher than 25 mg available.
Can you switch from the Wegovy injection to the pill?
Yes, if you are using Wegovy injection at a 2.4 mg maintenance dose, you may be able to switch to the oral pill form (25 mg), subject to approval by your prescriber. However, you should wait for one week after your last Wegovy injection before starting the Wegovy pill. Always consult with your healthcare provider before switching between the injection and pill forms to make sure the transition is safe and effective for you.
Does the Wegovy pill need to be refrigerated?
No, the Wegovy pill does not require refrigeration like Wegovy injections. Wegovy pill should be stored at room temperature (68°F to 77°F / 20°C to 25°C) in its original bottle, and kept in a dry place away from heat and humidity. This makes the pill easier to travel with and more convenient to store than the injectable version.
Is the Wegovy pill approved for teenagers?
No, the Wegovy pill is currently FDA-approved only for adults aged 18 and older. However, the injectable Wegovy pen is approved for adolescents ages 12 and older with obesity. Families considering treatment for a teenager should discuss with a pediatric healthcare provider whether the injectable form may be appropriate.
What is the difference between Wegovy Pill and Rybelsus?
Both the Wegovy pill and Rybelsus contain semaglutide as the active ingredient, but they are approved for different uses and come in different doses. Rybelsus is available in 7 mg and 14 mg tablets and is FDA-approved for type 2 diabetes management. The Wegovy pill contains a higher dose of oral semaglutide (up to 25 mg) and is FDA-approved for chronic weight management and lowering the cardiovascular risk in certain patients.
Why is the pill dose higher than the injection?
The Wegovy pill uses a higher dose because some of the medication is broken down in the stomach before it can be absorbed. The 25 mg oral dose of Wegovy is designed to deliver a similar amount of semaglutide into the bloodstream as the 2.4 mg weekly injection.
How long do you stay on the Wegovy pill?
Wegovy is usually prescribed long-term to manage chronic obesity. Most patients stay on Wegovy as long as it remains effective and well-tolerated. Stopping Wegovy can sometimes lead to weight regain. According to the Step 1 clinical trial, participants who stopped taking semaglutide regained two-thirds of the previously lost weight. Do not stop the medication on your own. Your healthcare provider will regularly review your progress to decide how long you should continue.
What foods should I avoid while taking Wegovy?
There is no strict “banned foods” list while taking Wegovy pills. However, there are certain foods that affect how the medication works and may worsen side effects like nausea, bloating, or stomach discomfort. These include;
- Fried and greasy foods, such as fried chicken
- High-fat meals like sausage, bacon, and a marbled cut of beef
- Sugary foods and drinks
- Large and heavy meals
- Highly processed foods such as potato chips
- Heavy cream-based sauces, gravies, and pastas
- Full-fat dairy milk and full-fat cheeses
- Alcohol
Therefore, try to limit these foods and eat smaller and more frequent meals to manage the side effects.
Conclusion: Is the Wegovy Pill right for you?
The Wegovy pill titration schedule is a gradual journey. While the 25 mg maintenance dose is the long-term target for chronic weight management, reaching it safely requires following the recommended 30-day dose escalation steps to help your body adjust and reduce gastrointestinal side effects.
While this dosing chart provides a standard roadmap, your healthcare provider may adjust your schedule based on your individual health profile, treatment response, and tolerability. As Wegovy is a prescription medication, always consult a licensed healthcare provider before starting, stopping, or changing your dose.
It is important to remember that even the correct dose may not work properly if the administration instructions are not followed. Take the pill in the morning, with minimal plain water, and wait at least 30 minutes before eating or drinking for proper semaglutide absorption and long-term weight-loss success. If you don’t follow the administration protocol, even the correct dose will not show significant results.
